30 likes | 42 Views
The Global Womenu2019s Healthcare Market appraised at USD 9.6 billion in 2019 is expected to reach USD 23.81 billion by 2026, at a CAGR of 13.2 % during the projection period.
E N D
Turnover of Global Women's Healthcare Market to Grow at Staggering CAGR of 13.2% and Surpass USD 23.81 Billion by 2026
The Global Women’s Healthcare Market assessed at USD 9.6 billion in 2019 is expected to reach USD 23.81 billion by 2026, at a CAGR of 13.2 % during the projection period. Women's health issues are unique as they relate to women's anatomy and reproductive system and need to be addressed uniquely. There are wide range of health conditions pertaining menstruation, pregnancy, menopause, contraception that need diagnosis and treatment by medical professionals. Women's health issues have gained prominent recognition in recent decades. Effective policies and government initiatives help reduce the women's health problems and allow them live healthier lives. However, some significant gender-based health disparities remain in many countries. Lack of awareness and lower income levels in many developing countries make healthcare services difficult or inaccessible for women. The growth of healthcare market is mainly governed by the rising incidence of chronic ailments among women, government initiatives to control population, and growing requests for contraceptives to avoid unintentional pregnancies.
Prolia segment plays a significant role in the Women’s Healthcare Market • Based on the drug, the market is divided into Mirena, Zometa, Reclast, Prolia, Xgeva, Evista, Nuvaring, Primarin, and Actonel. Prolia is the fastest-growing section of the market and it captured the significant share of the market in 2018. The increasing incidence of postmenopausal osteoporosis is the factor contributing to the rising demand for Prolia, its market growth and robust market share. • Postmenopausal Osteoporosis section dominates all the applications in Women’s Healthcare market • The market is divided into contraceptives, menopause, PCOS, hormonal infertility, postmenopausal osteoporosis, endometriosis, and other based on application. In 2018, the postmenopausal osteoporosis section accounted for the leading market share and is expected to maintain its share during the prediction period. Read More: https://www.blueweaveconsulting.com/women%E2%80%99s-healthcare-market-bwc20103